stock - The general public is conditioned to read this kind of Merck development without paying attention to it's implications, and what Merck's rep said on record, only after being called out. It reminds me of what KG has said in public, where he tells you, exactly what he's doing. The Merck representative called the SC trial deaths as nearly equivalent to results found with IV administration. On the face it, that's a lie. The claim is that the sample size was too small, but then the difference is worse, than it is close🤔 They designed the trial, but when the result isn't to their liking, they deploy two methods, going under the radar, or worse, obfuscation with double speak or outright lying.
Market Data 
Markets 
AI
